Testosterone Replacement Therapy in the VA Setting

Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Testosterone Replacement Therapy in the VA Setting
Men's Sexual Health Consult Collection

Article PDF
Author and Disclosure Information

James V. Felicetta, MD, Alvin M. Matsumoto, MD, Adrian Dobs, MD, Diala El-Maouche, MD, Glenn R. Cunningham, MD, Sumbul Beg, MD, Lara Al-Khoury Nabbout, MD

Dr. Felicetta is the chairman of the department of medicine at the Carl T. Hayden VA Medical Center, Phoenix, AZ, and a professor of clinical medicine at the University of Arizona, Tucson. Dr. Matsumoto is a professor in the department of medicine at the University of Washington School of Medicine, Seattle, WA, as well as the associate director of the Geriatric Research, Education and Clinical Center and the director of the clinical research unit at the VA Puget Sound Health Care System, all in Seattle, WA. Dr. Dobs is professor of medicine and oncology in the School of Medicine, and Dr. El-Maouche is a postdoctoral fellow in the division of endocrinology and metabolism, both at Johns Hopkins University, Baltimore, MD. Dr. Cunningham is a professor in the departments of medicine and molecular and cellular biology at Baylor College of Medicine, Houston, TX. He is also medical director of the Diabetes Program at St. Luke's Episcopal Hospital, Houston. Dr. Beg is a second-year fellow in endocrinology in the department of medicine at Baylor College of Medicine and the medical service at St. Luke's Episcopal Hospital. Dr. Nabbout is a visiting fellow in endocrinology in the medical service at St. Luke's Episcopal Hospital.

Publications
Topics
Page Number
1–25
Legacy Keywords
male, men, men's, sexual, testosterone, testosterone replacement therapy, TRT, erectile dysfunction, ED, impotence, hypogonadism, androgen deficiency, total testosterone, T, T level, T levels, testosterone enanthate, TE, esters, pellets, buccal, patch, gel, intramuscular injection, implantable, transbuccal, transdermal, adverse effects, Klinefelter syndrome, Klinefelter's syndrome, sex hormone binding globulin, SHGB, prostate-specific antigen, PSA, hematocrit, hemoglobin, digital rectal examination, dual energy x-ray absorptiometry, DEXA
Author and Disclosure Information

James V. Felicetta, MD, Alvin M. Matsumoto, MD, Adrian Dobs, MD, Diala El-Maouche, MD, Glenn R. Cunningham, MD, Sumbul Beg, MD, Lara Al-Khoury Nabbout, MD

Dr. Felicetta is the chairman of the department of medicine at the Carl T. Hayden VA Medical Center, Phoenix, AZ, and a professor of clinical medicine at the University of Arizona, Tucson. Dr. Matsumoto is a professor in the department of medicine at the University of Washington School of Medicine, Seattle, WA, as well as the associate director of the Geriatric Research, Education and Clinical Center and the director of the clinical research unit at the VA Puget Sound Health Care System, all in Seattle, WA. Dr. Dobs is professor of medicine and oncology in the School of Medicine, and Dr. El-Maouche is a postdoctoral fellow in the division of endocrinology and metabolism, both at Johns Hopkins University, Baltimore, MD. Dr. Cunningham is a professor in the departments of medicine and molecular and cellular biology at Baylor College of Medicine, Houston, TX. He is also medical director of the Diabetes Program at St. Luke's Episcopal Hospital, Houston. Dr. Beg is a second-year fellow in endocrinology in the department of medicine at Baylor College of Medicine and the medical service at St. Luke's Episcopal Hospital. Dr. Nabbout is a visiting fellow in endocrinology in the medical service at St. Luke's Episcopal Hospital.

Author and Disclosure Information

James V. Felicetta, MD, Alvin M. Matsumoto, MD, Adrian Dobs, MD, Diala El-Maouche, MD, Glenn R. Cunningham, MD, Sumbul Beg, MD, Lara Al-Khoury Nabbout, MD

Dr. Felicetta is the chairman of the department of medicine at the Carl T. Hayden VA Medical Center, Phoenix, AZ, and a professor of clinical medicine at the University of Arizona, Tucson. Dr. Matsumoto is a professor in the department of medicine at the University of Washington School of Medicine, Seattle, WA, as well as the associate director of the Geriatric Research, Education and Clinical Center and the director of the clinical research unit at the VA Puget Sound Health Care System, all in Seattle, WA. Dr. Dobs is professor of medicine and oncology in the School of Medicine, and Dr. El-Maouche is a postdoctoral fellow in the division of endocrinology and metabolism, both at Johns Hopkins University, Baltimore, MD. Dr. Cunningham is a professor in the departments of medicine and molecular and cellular biology at Baylor College of Medicine, Houston, TX. He is also medical director of the Diabetes Program at St. Luke's Episcopal Hospital, Houston. Dr. Beg is a second-year fellow in endocrinology in the department of medicine at Baylor College of Medicine and the medical service at St. Luke's Episcopal Hospital. Dr. Nabbout is a visiting fellow in endocrinology in the medical service at St. Luke's Episcopal Hospital.

Article PDF
Article PDF
Men's Sexual Health Consult Collection
Men's Sexual Health Consult Collection

Page Number
1–25
Page Number
1–25
Publications
Publications
Topics
Article Type
Display Headline
Testosterone Replacement Therapy in the VA Setting
Display Headline
Testosterone Replacement Therapy in the VA Setting
Legacy Keywords
male, men, men's, sexual, testosterone, testosterone replacement therapy, TRT, erectile dysfunction, ED, impotence, hypogonadism, androgen deficiency, total testosterone, T, T level, T levels, testosterone enanthate, TE, esters, pellets, buccal, patch, gel, intramuscular injection, implantable, transbuccal, transdermal, adverse effects, Klinefelter syndrome, Klinefelter's syndrome, sex hormone binding globulin, SHGB, prostate-specific antigen, PSA, hematocrit, hemoglobin, digital rectal examination, dual energy x-ray absorptiometry, DEXA
Legacy Keywords
male, men, men's, sexual, testosterone, testosterone replacement therapy, TRT, erectile dysfunction, ED, impotence, hypogonadism, androgen deficiency, total testosterone, T, T level, T levels, testosterone enanthate, TE, esters, pellets, buccal, patch, gel, intramuscular injection, implantable, transbuccal, transdermal, adverse effects, Klinefelter syndrome, Klinefelter's syndrome, sex hormone binding globulin, SHGB, prostate-specific antigen, PSA, hematocrit, hemoglobin, digital rectal examination, dual energy x-ray absorptiometry, DEXA
Article Source

Citation Override
Fed Pract. 2008;25(suppl 2):1–25.
PURLs Copyright

Inside the Article

Article PDF Media